https://www.pharmaglobenewswire.com/iga-nephropathy-market-set-to-surpass-usd-1-5-billion-in-2025-amid-rising-disease-awareness-novel-therapies-and-expanding-treatment-landscape-across-seven-major-markets/Pharma Globenewswireen2026-04-24T11:09:53+01:00IgA Nephropathy Market Set to Surpass USD 1.5 Billion in 2025 Amid Rising Disease Awareness, Novel Therapies, and Expanding Treatment Landscape Across Seven Major Markets https://www.pharmaglobenewswire.com/thyroid-eye-disease-pipeline-accelerates-with-20-companies-advancing-innovative-therapies-across-clinical-stages/Pharma Globenewswireen2026-04-23T18:37:50+01:00Thyroid Eye Disease Pipeline Accelerates with 20+ Companies Advancing Innovative Therapies Across Clinical Stages https://www.pharmaglobenewswire.com/acute-myocardial-infarction-market-set-to-surge-from-usd-1630-million-in-2025-to-usd-5392-million-by-2034-driven-by-innovative-therapies-and-rising-cardiovascular-disease-burden/Pharma Globenewswireen2026-04-23T12:14:15+01:00Acute Myocardial Infarction Market Set to Surge from USD 1,630 Million in 2025 to USD 5,392 Million by 2034, Driven by Innovative Therapies and Rising Cardiovascular Disease Burden